OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.

about

Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.The number of titrated microRNA species dictates ceRNA regulation.

P2860

Q53681441-5611EE8C-EEE2-4A95-A58B-E7B2A323A808 Q55209763-DF3A0BBF-83E0-4E48-B41D-F81BA7F8ADBA

P2860

OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.

Item

http://www.wikidata.org/entity/Q38893887

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

OCT4 controls mitotic stabilit ...... ovarian cancer aggressiveness.

@en

type

Item

label

OCT4 controls mitotic stabilit ...... ovarian cancer aggressiveness.

@en

prefLabel

OCT4 controls mitotic stabilit ...... ovarian cancer aggressiveness.

@en

P1476

OCT4 controls mitotic stabilit ...... ovarian cancer aggressiveness

@en

P2093

C Schneider

http://www.w3.org/2001/XMLSchema#string

E Comisso

http://www.w3.org/2001/XMLSchema#string

L Mariuzzi

http://www.w3.org/2001/XMLSchema#string

M Orsaria

http://www.w3.org/2001/XMLSchema#string

M Scarola

http://www.w3.org/2001/XMLSchema#string

R Benetti

http://www.w3.org/2001/XMLSchema#string

S Marzinotto

http://www.w3.org/2001/XMLSchema#string

S Schoeftner

http://www.w3.org/2001/XMLSchema#string

P2860

Loss of pRB causes centromere dysfunction and chromosomal instability

Cell division: control of the chromosomal passenger complex in time and space

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.

Integrated genomic analyses of ovarian carcinoma

The retinoblastoma protein and cell cycle control

Aurora-B associated protein phosphatases as negative regulators of kinase activation

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells

Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.

P2888

onc.2017.20

P304

4253-4266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2017.20

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Silvano Piazza

Yari Ciani

M Rosso

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084129915

http://www.w3.org/2001/XMLSchema#string

P698

28319064

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.

about

P2860

P2860

OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921